Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 4/20 | 0.51 |
| ▸ | CNR1 | P21554 | 2/20 | 0.50 |
| ▸ | CNR2 | P34972 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL118480 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL117739 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL1503636 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL118129 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL18297784 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL23921985 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL375162 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL18297783 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL118128 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 | |
| SCHEMBL2801944 | 1.00 | FASN (0.53) | FASNKDM4EMAPTFAAHCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117800839-A | Composition containing eicosapentaenoic acid ethyl ester and preparation method and application thereof | 浙江可明生物医药有限公司 | 2024-04-02 | — | — | CN | claimed |
| US-20210369668-A1 | COMPOSITION EXHIBITING ENHANCED OXIDATIVE STABILITY | DSM IP ASSETS B.V. (NL) | 2021-12-02 | — | — | US | claimed |
| US-11148993-B1 | Method for purifying polyunsaturated fatty acid by using continuous reactor | CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO. LTD. (TW) | 2021-10-19 | — | — | US | claimed |
| US-10888537-B2 | Pharmaceutical compositions comprising omega-3 fatty acids | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2021-01-12 | — | — | US | claimed |
| EP-3103787-B1 | METHOD FOR CHEMICAL CONVERSION OF UNSATURATED FATTY ACID BY CARBON CHAIN EXTENSION REACTION | BIZEN CHEMICAL CO LTD (JP) | 2020-03-04 | — | — | EP | claimed |
| CN-110585188-A | Lipids and lipid compounds for use as medicaments for the treatment of pain and methods of use thereof | 崔建国 | 2019-12-20 | — | — | CN | claimed |
| US-20190054063-A1 | NOVEL TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES | DSM IP ASSETS B.V. (NL) | 2019-02-21 | — | — | US | claimed |
| US-20150272917-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2015-10-01 | — | — | US | claimed |
| EP-2661483-A1 | CARRIER FLUID COMPOSITION COMPRISING FATTY ACIDS ETHYL ESTERS AND PROCESS FOR REDUCING THE CONCENTRATION OF PERSISTENT ORGANIC POLLUTANTS IN FISH OIL | Naturalis S.A. (CL) | 2013-11-13 | — | — | EP | claimed |
| WO-2013102800-A1 | CARRIER FLUID COMPOSITION COMPRISING FATTY ACIDS ETHYL ESTERS AND PROCESS FOR REDUCING THE CONCENTRATION OF PERSISTENT ORGANIC POLLUTANTS IN FISH OIL | NATURALIS S.A. (CL) | 2013-07-11 | — | — | WO | claimed |
| US-8258330-B1 | Carrier fluid composition comprising fatty acids ethyl esters and process for reducing the concentration of persistent organic pollutants in fish oil | Naturalis, S.A. (CL) | 2012-09-04 | — | — | US | claimed |
| CN-119613260-A | Method for reducing content of low-boiling-point substances and high-boiling-point substances in polyethylenglycol and application thereof | 山东新华制药股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119286591-A | Synthesis process of triglyceride type fish oil and triglyceride type fish oil | 舟山新诺佳生物工程有限责任公司 | 2025-01-10 | — | — | CN | disclosed |
| EP-3640317-B1 | METHOD FOR PRODUCING POLYUNSATURATED FATTY ACID-CONTAINING COMPOSITION | NISSHIN PHARMA INC (JP) | 2024-05-29 | — | — | EP | disclosed |
| CN-117800839-A | Composition containing eicosapentaenoic acid ethyl ester and preparation method and application thereof | 浙江可明生物医药有限公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2008098375-A1 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES, AND USES THEREOF | CENTRE DE RECHERCHE SUR LES BIOTECHNOLOGIES MARINES (CA) | 2008-08-21 | — | — | WO | disclosed |
| US-7365219-B2 | Solid phase extraction method for obtaining high-purity unsaturated compounds or derivatives of said compounds | NUTRINOVA NUTRITION SPECIALTIES & FOOD INDREDIENTS GMBH (DE) | 2008-04-29 | — | — | US | disclosed |
| US-20040162437-A1 | Solid phase extraction method for obtaining high-purity unsaturated compounds or derivatives of said compounds | NUTRINOVA NUTRITION SPECIALIST & FOOD INGREDIENTS GMBH (DE) | 2004-08-19 | — | — | US | disclosed |
| EP-1392621-A2 | SOLID PHASE EXTRACTION METHOD FOR OBTAINING HIGH-PURITY UNSATURATED COMPOUNDS OR DERIVATIVES OF SAID COMPOUNDS | Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002098826-A2 | SOLID PHASE EXTRACTION METHOD FOR ISOLATING UNSATURATED COMPOUNDS | NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) | 2002-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10888537-B2 | Pharmaceutical compositions comprising omega-3 fatty acids | ELOVL3, ELOVL6, ELOVL5 | FASN 21/4885KDM4E 4690/4885MAPT 3257/4885 |
| US-20190054063-A1 | NOVEL TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES | FABP1, LIPC, SCD | FASN 8/4885KDM4E 1197/4885MAPT 3397/4885 |
| US-20150272917-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS | ELOVL3, ELOVL6, ELOVL5 | FASN 21/4885KDM4E 4690/4885MAPT 3257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.